STOCK TITAN

APLS insider plans Rule 144 sale after recent stock disposals

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

APLS insider plans a new stock sale under Rule 144. A notice was filed to sell 27,192 shares of common stock through Fidelity Brokerage Services LLC on the NASDAQ, with an approximate sale date of 01/22/2026. The filing lists an aggregate market value of 591,844.76 for these shares and notes that 126,525,218 common shares are outstanding.

The 27,192 shares to be sold were acquired on 01/21/2026 through restricted stock vesting from the issuer as compensation, with payment also dated 01/21/2026. The notice also reports prior sales over the past three months by Cedric Francois at the same address, including 10,186 common shares sold on 01/13/2026 for gross proceeds of 225,998.82 and 8,182 common shares sold on 01/20/2026 for gross proceeds of 161,945.51. The signer represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the APLS Form 144 notice disclose about upcoming stock sales?

The notice discloses an intent to sell 27,192 shares of APLS common stock through Fidelity Brokerage Services LLC on the NASDAQ, with an approximate sale date of 01/22/2026 and an aggregate market value of 591,844.76.

How were the 27,192 APLS common shares being sold under Form 144 acquired?

The 27,192 common shares were acquired on 01/21/2026 via restricted stock vesting from the issuer as compensation, with the date of payment also listed as 01/21/2026.

What recent APLS stock sales by Cedric Francois are reported in this Form 144?

The notice lists sales by Cedric Francois of 10,186 common shares on 01/13/2026 for gross proceeds of 225,998.82 and 8,182 common shares on 01/20/2026 for gross proceeds of 161,945.51.

What is the total number of APLS common shares outstanding mentioned in the Form 144?

The Form 144 states that there are 126,525,218 common shares outstanding.

Which broker and exchange are involved in the planned APLS share sale?

The planned sale will be executed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, and the shares are to be sold on the NASDAQ.

What representation does the seller make about inside information in this APLS Form 144?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Apellis Pharmace

NASDAQ:APLS

APLS Rankings

APLS Latest News

APLS Latest SEC Filings

APLS Stock Data

2.75B
106.56M
13.68%
105.74%
16.26%
Biotechnology
Pharmaceutical Preparations
Link
United States
WALTHAM